$SPY stock has risen 0.4% today, according to our price data from Polygon. It has been bolstered by MRNA stock rising 129.3%.
Here are some of the largest contributors to SPY's gains:
- $AAPL (6.7% of SPY holdings) has risen 2.0%
- $MSFT (5.3%) has risen 1.5%
- $AMZN (3.8%) has risen 1.9%
- $MRK (0.5%) has risen 10.9%
- $LLY (1.4%) has risen 3.6%
- $MRNA (0.0%) has risen 129.3%
- $TSLA (1.4%) has risen 3.0%
- $META (1.9%) has risen 1.6%
- $MRVL (0.3%) has risen 8.1%
- $NFLX (0.5%) has risen 3.6%
You can track more data on $SPY on Quiver Quantitative's $SPY data dashboard.
$MRNA Insider Trading Activity
$MRNA insiders have traded $MRNA stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $MRNA stock by insiders over the last 6 months:
- STEPHANE BANCEL (Chief Executive Officer) has made 0 purchases and 4 sales selling 499,246 shares for an estimated $28,715,011.
- STEPHEN HOGE (President) has made 0 purchases and 4 sales selling 320,017 shares for an estimated $16,741,685.
- SHANNON THYME KLINGER (Chief Legal Officer) has made 0 purchases and 2 sales selling 17,356 shares for an estimated $899,596.
- NOUBAR AFEYAN sold 9,263 shares for an estimated $433,878
- ABBAS HUSSAIN sold 5,682 shares for an estimated $264,951
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MRNA Analyst Ratings
Wall Street analysts have issued reports on $MRNA in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 02/23/2026
To track analyst ratings and price targets for $MRNA, check out Quiver Quantitative's $MRNA forecast page.
$MRNA Price Targets
Multiple analysts have issued price targets for $MRNA recently. We have seen 8 analysts offer price targets for $MRNA in the last 6 months, with a median target of $46.5.
Here are some recent targets:
- Matthew Harrison from Morgan Stanley set a target price of $39.0 on 07/08/2026
- Luca Issi from RBC Capital set a target price of $45.0 on 07/07/2026
- Dimple Gosai from B of A Securities set a target price of $38.0 on 07/07/2026
- Edward Tenthoff from Piper Sandler set a target price of $77.0 on 06/26/2026
- Salveen Richter from Goldman Sachs set a target price of $49.0 on 05/04/2026
- Cory Kasimov from Evercore ISI Group set a target price of $50.0 on 05/04/2026
- Eliana Merle from UBS set a target price of $45.0 on 05/04/2026
You can track data on $MRNA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
